Alosetron is approved for which population?
1. Women with diarrhea-predominant IBS
2. Men with constipation and crampy abdominal pain
3. Pregnant women with iron-associated constipation
4. Children whose growth rate is reduced because of IBS
Question 2
Tegaserod should not be administered to patients with:
1. severe renal impairment.
2. constipation.
3. sulfa allergy.
4. weight gain.